Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ (@arvindcanchi) 's Twitter Profile
Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ

@arvindcanchi

Nephrologist & Transplant Physician, Bangalore/Trustwell/Sagar Hospitals | Co-Founder @Bloom_Value | Chair: @isn_india SoMe | Member- ISN SARB | #ECNeph Creator

ID: 2913871934

linkhttp://bloomvalue.com calendar_today29-11-2014 15:26:34

37,37K Tweet

10,10K Takipรงi

1,1K Takip Edilen

World Congress of Nephrology (@isnwcn) 's Twitter Profile Photo

WCNโ€™25 abstract submission deadline is fast approachingโ€ผ๏ธ Donโ€™t miss the chance to impact the future of kidney care by sharing your research at #ISNWCNโ€”four more days to submit your work. ow.ly/S0jU50SQgQU

WCNโ€™25 abstract submission deadline is fast approachingโ€ผ๏ธ

Donโ€™t miss the chance to impact the future of kidney care by sharing your research at #ISNWCNโ€”four more days to submit your work.

ow.ly/S0jU50SQgQU
Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ (@arvindcanchi) 's Twitter Profile Photo

FINEARTS-HF Trial ยป ๐…๐ข๐ง๐ž๐ซ๐ž๐ง๐จ๐ง๐ž ๐ซ๐ž๐๐ฎ๐œ๐ž๐ ๐ญ๐ก๐ž ๐ข๐ง๐œ๐ข๐๐ž๐ง๐œ๐ž ๐จ๐Ÿ ๐ง๐ž๐ฐ #๐๐ข๐š๐›๐ž๐ญ๐ž๐ฌ ๐›๐ฒ ๐š๐›๐จ๐ฎ๐ญ ๐š ๐ช๐ฎ๐š๐ซ๐ญ๐ž๐ซ ๐ข๐ง ๐ฉ๐š๐ญ๐ข๐ž๐ง๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ก๐ž๐š๐ซ๐ญ ๐Ÿ๐š๐ข๐ฅ๐ฎ๐ซ๐ž ๐ฐ๐ข๐ญ๐ก ๐ฆ๐ข๐ฅ๐๐ฅ๐ฒ ๐ซ๐ž๐๐ฎ๐œ๐ž๐ ๐จ๐ซ ๐ฉ๐ซ๐ž๐ฌ๐ž๐ซ๐ฏ๐ž๐ ๐ž๐ฃ๐ž๐œ๐ญ๐ข๐จ๐ง

FINEARTS-HF Trial
ยป ๐…๐ข๐ง๐ž๐ซ๐ž๐ง๐จ๐ง๐ž ๐ซ๐ž๐๐ฎ๐œ๐ž๐ ๐ญ๐ก๐ž ๐ข๐ง๐œ๐ข๐๐ž๐ง๐œ๐ž ๐จ๐Ÿ ๐ง๐ž๐ฐ #๐๐ข๐š๐›๐ž๐ญ๐ž๐ฌ ๐›๐ฒ ๐š๐›๐จ๐ฎ๐ญ ๐š ๐ช๐ฎ๐š๐ซ๐ญ๐ž๐ซ ๐ข๐ง ๐ฉ๐š๐ญ๐ข๐ž๐ง๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ก๐ž๐š๐ซ๐ญ ๐Ÿ๐š๐ข๐ฅ๐ฎ๐ซ๐ž ๐ฐ๐ข๐ญ๐ก ๐ฆ๐ข๐ฅ๐๐ฅ๐ฒ ๐ซ๐ž๐๐ฎ๐œ๐ž๐ ๐จ๐ซ ๐ฉ๐ซ๐ž๐ฌ๐ž๐ซ๐ฏ๐ž๐ ๐ž๐ฃ๐ž๐œ๐ญ๐ข๐จ๐ง
Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ (@arvindcanchi) 's Twitter Profile Photo

Hi all this is Arvind Canchi Bangalore based Nephrologist at the #NephJC. Just go onto Instagram a few weeks ago. Looking at pt education there. Follow me on Insta! Same id Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ BTW, I follow all things BP and there is this study from Norway on BP and stroke risk

Hi all this is Arvind Canchi Bangalore based Nephrologist at the  #NephJC. 
Just go onto <a href="/instagram/">Instagram</a> a few weeks ago. Looking at pt education there. Follow me on Insta! Same id <a href="/arvindcanchi/">Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ</a> 
BTW, I follow all things BP and there is this study from Norway on  BP and stroke risk
Cristina Popa (@nephroseeker) 's Twitter Profile Photo

Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ Indian Society of Nephrology ECNeph ISN Education My country is not that far. Older study, considered controlled BP if SBP < 140, but still around 20% controlled BP. HTN prevalence back then approx 40% (according to European definition of HTN) #nephjc journals.lww.com/jhypertension/โ€ฆ

<a href="/arvindcanchi/">Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ</a> <a href="/isn_india/">Indian Society of Nephrology</a> <a href="/ECNeph/">ECNeph</a> <a href="/ISNeducation/">ISN Education</a> My country is not that far. Older study, considered controlled BP if SBP &lt; 140, but still around 20% controlled BP.

HTN prevalence back then approx 40% (according to European definition of HTN)  #nephjc 
journals.lww.com/jhypertension/โ€ฆ
Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ (@arvindcanchi) 's Twitter Profile Photo

๐Ÿ’ฅAnd the 2nd point, pts in a trial ate generally looked after well with a close follow up ensuring an early look at any adverse event. What about my pts, where in gonna get aggressive about BP control and I don't get to see him or her for a couple of months or more? ๐Ÿ’ฅGetting

Prachi (@prachipath123) 's Twitter Profile Photo

โญ•๏ธ49 year male โญ•๏ธ loss of vision and headache โญ•๏ธExcision of tumour โญ•๏ธAttached supportive IHC โญ•๏ธDx- ????๐Ÿ™‡โ€โ™€๏ธ๐Ÿ€๐Ÿ’š โฆDr John Hayes Jrโฉ โฆEducational Pathology Tweet Awardโฉ โฆFaisal Mahmoodโฉ โฆSanjay Mukhopadhyayโฉ โฆOlaleke Folaranmiโฉ โฆPathological Porkโฉ โฆ Peaceful Evening ahead ๐Ÿ’

โญ•๏ธ49 year male
โญ•๏ธ loss of vision and headache 
โญ•๏ธExcision of tumour 
โญ•๏ธAttached supportive IHC 
โญ•๏ธDx- ????๐Ÿ™‡โ€โ™€๏ธ๐Ÿ€๐Ÿ’š
โฆ<a href="/NeuropathyDoc/">Dr John Hayes Jr</a>โฉ โฆ<a href="/PathTweetAward/">Educational Pathology Tweet Award</a>โฉ โฆ<a href="/AI4Pathology/">Faisal Mahmood</a>โฉ โฆ<a href="/smlungpathguy/">Sanjay Mukhopadhyay</a>โฉ โฆ<a href="/DrGeeONE/">Olaleke Folaranmi</a>โฉ โฆ<a href="/PathologicalPrk/">Pathological Pork</a>โฉ โฆ
Peaceful Evening ahead ๐Ÿ’
Vinant bhargava (@vinbhargava) 's Twitter Profile Photo

๐Ÿ‘ โญ๏ธ Dr Santosh Varughese and the entire editorial team on the herculean task of releasing the online issue of PD journal of India. In the dying world of PD, itโ€™s ๐Ÿคฉ to see two of our manuscripts Peritoneal Dialysis Society India PDSI India Int. Soc. for Peritoneal Dialysis Peritoneal Dialysis International Journal Dr Prof Manisha Sahay

๐Ÿ‘ โญ๏ธ Dr Santosh Varughese and the entire editorial team on the herculean task of releasing the online issue of PD journal of India. In the dying world of PD, itโ€™s ๐Ÿคฉ to see two of our manuscripts <a href="/pdsiindia/">Peritoneal Dialysis Society India</a> <a href="/IndiaPDSI/">PDSI India</a> <a href="/ISPD1/">Int. Soc. for Peritoneal Dialysis</a> <a href="/PDI_Journal/">Peritoneal Dialysis International Journal</a> <a href="/drmanishasahay/">Dr Prof Manisha Sahay</a>
Swetha Kanduri (@swethakandurimd) 's Twitter Profile Photo

Management of Newly diagnosed MM: โ€ผ๏ธDara-VRd for standard risk โ€ผ๏ธDara- KRd for high risk as induction for transplant eligible patients โ€ผ๏ธAnti- Cd38 monoclonal antibody based quadruple induction therapy provides better response โ€ผ๏ธSaad Z. Usmani MD MBA FACP ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ต๐Ÿ‡ฐ American Society of Onconephrology Memorial Sloan Kettering Nephrology MSK CME

Management of Newly diagnosed MM: โ€ผ๏ธDara-VRd for standard risk 
โ€ผ๏ธDara- KRd for high risk as induction for transplant eligible patients 
โ€ผ๏ธAnti- Cd38 monoclonal antibody based quadruple induction therapy provides better response 
โ€ผ๏ธ<a href="/szusmani/">Saad Z. Usmani MD MBA FACP ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ต๐Ÿ‡ฐ</a> <a href="/onconephsociety/">American Society of Onconephrology</a> <a href="/MSK_Neph/">Memorial Sloan Kettering Nephrology</a> <a href="/MSKCME/">MSK CME</a>